Navigation Links
58% of Physicians Support FDA Move to Pull Breast Cancer Indication from Avastin
Date:2/4/2011

CAMBRIDGE, Mass., Feb. 4, 2011 /PRNewswire/ -- Sermo (http://www.sermo.com), the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the treatment of breast cancer.  The new report titled "Should Avastin (bevacizumab) Keep its Breast Cancer Indication?" reveals how physicians are using Avastin and which therapeutic agents they will switch to for clinical presentations.

58% of physician respondents support the FDA's move to pull the breast cancer indication from Avastin. However, 50% of respondents also believe that Avastin has increased the quality of life for breast cancer patients.

Physicians provided commentary on both sides of the debate. Some believe that the progression free survival benefit previously shown for Avastin is meaningful.  According to one oncologist on Sermo, "...if folks can get 'caught up' on the survival endpoint by being able to take Avastin at the time of progression, how can one possibly prove a survival advantage overall." Another oncologist commented, "This is a shame, but we are going to do what the payers let us do."

Therapeutic agents listed by physicians that will be used instead of Avastin in the treatment of breast cancer include, but are not limited to Resveratrol, Abraxane (paclitaxel), Taxotere (docetaxel), Gemzar (gemcitabine), Xeloda (capecitabine), Abraxane (paclitaxel), Taxol (paclitaxel), Navelbine (Vinorelbine) and Ixempra (ixabepilone).

Many of the respondents also participated in an online discussion regarding the original Avastin study. The full report includes:

  • Overview of FDA decision
  • Report methodology
  • Key findings
  • Discussion highlights
  • Changes in physician perception from 2009-2010
  • Therapeutic agents physicians will use in place of Avastin

To download full results of this free report, visit sermo.com/client.

About Sermo Reports

Sermo Reports solicit perceptions and opinions from physicians about new drugs, devices, treatments, trends, and other topics of interest. Data for Sermo Reports is gathered through Sermo Posts, which allow physicians to participate in a poll and comment on the topic.  All physicians on Sermo are verified and credentialed.

About Sermo

Sermo is the largest online physician community, where over 117,000 practicing physicians discuss a wide range of issues from clinical cases to advice about drugs and practice management. By leveraging Sermo's social media platform, clients can tap into unsolicited, peer-to-peer dialog and engage MDs to gain market intelligence and increase brand awareness. For more information, visit www.sermo.com/client.


'/>"/>
SOURCE Sermo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aprima Electronic Health Record a Top Choice for Colorado Physicians
2. Healthy Advice® Networks Physicians Discuss Patient Adherence Challenges at National Conference
3. Millennium Laboratories to Provide UnitedHealthcares Nationwide Network of Physicians Drug Monitoring and Pain Management Services
4. Consolidated Portland, Maine Healthcare Market Will Hamper Pharmaceutical Reps Access to Physicians
5. Sermo Study Shows 63% of Physicians Would Utilize New Gout Treatments
6. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
7. Activity Against Key Drug-Resistant Pathogens is the Most Important Attribute Influencing Surveyed Physicians Antibiotic Selection for Nosocomial Pneumonia in the U.S.
8. MedSolutions Offers Free CME Credit Imaging Safety Webinar for Physicians
9. Emergency Physicians Urge Americans to Take The American Medicine Chest Challenge November 13th
10. Physicians Pharmaceutical Corporation Offers Innovative On-Site Drug Dispensaries
11. Professional Liability Costs for Hospitals and Physicians Continue to Rise, Outpacing Inflation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)... WHIPPANY, N.J. , July 11, 2017  Bayer has ... across eight countries as part of its prestigious Bayer Hemophilia ... Children,s Hospital of Philadelphia and Uniformed ... are among the winners. Grant recipients were announced ... Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, ... urinalysis diagnostic testing equipment as well as middleware ... a way to make quality assurance easier and ... "Sysmex is well known for the innovation that ... Quality Monitor elevates quality assurance processes to a ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... ... A July 5th article on Reuters Health News discusses a ... body contouring procedure reported experiencing a better quality of life, compared to other patients. ... types of procedures, notes that this report jibes with what they regularly hear from ...
(Date:7/20/2017)... , ... July 20, 2017 , ... “Lucky the Buffalo and Her Adventures”: a collection ... published author, Edward Bieniek. Edward Steven Bieniek Jr. was born in Toledo, Ohio. ... Toledo at com tech. He is married to a brilliant woman with a caring ...
(Date:7/18/2017)... ... 18, 2017 , ... ClinicalTrials.gov and the New Final Rule ... Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. – 3:00 p.m. ... Clinical Trials Registration and Results Information,” is a head-scratcher. After reading and re-reading ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, Wash., knows the ... I have frequent hot flashes, and I suffer from anxiety and vertigo on top ... cool while out and about." INSTA-FAN meets that need. , This device enables a ...
(Date:7/18/2017)... (PRWEB) , ... July 19, 2017 , ... ... Winner for it’s Corporate Social Responsibility Initiative in the prestigious CEO World Awards®. ... leadership, innovation, organizational performance, new products and services, CEO case studies, corporate social ...
Breaking Medicine News(10 mins):